ATS Medical reports first commercial procedure using its sutureless aortic valve
Chief Executive Michael Dale called the procedures a "major milestone" for the company, which eventually hopes to bring the valve to the traditional surgery market.
Chief Executive Michael Dale called the procedures a "major milestone" for the company, which eventually hopes to bring the valve to the traditional surgery market.
Cardiology device maker ATS Medical Inc. saw its stock plummet 17 percent in early afternoon trading Tuesday, a day after the company announced that it expects losses for the fourth quarter and full year of 2009.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Rhythmia is developing a device used to treat heart arrhythmia or abnormal beating, a condition that can lead to heart disease and stroke.
Cardiology device maker ATS Medical Inc. has been issued a patent for technology used in implantable devices that involves a laser-based system for cutting tissues.
The company says the device allows for less-invasive aortic valve replacement and shorter procedure times than other commercially available alternatives.